Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

October 15, 2018

Primary Completion Date

July 13, 2020

Study Completion Date

November 16, 2020

Conditions

BK Virus Nephropathy

Interventions

BIOLOGICAL

MAU868

MAU868 infused i.v. over 1 hour. One dose will be administered monthly for a total of 6 doses.

BIOLOGICAL

Placebo

Solution containing no active excipients, infused i.v. over 1 hour. One dose will be administered monthly for a total of 6 doses